Liang-In Lin

15PUBLICATIONS
22CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapyPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 17, 2026
Modulating metabolic signatures to mitigate cabozantinib resistance in FLT3-ITD acute myeloid leukemia cell models.

Yu-Hsuan Fu, Kit Man Ng, Chi-Yang Tseng

|Jul 10, 2025
Ropeginterferon alfa-2b as a promising alternative to conventional interferon in CDA type 1: a case report of two siblings.

Tyng-Wei Yang, Xavier Cheng-Hong Tsai, Yu-Hsuan Fu

|May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.

Sao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai

|Oct 11, 2023
Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis.

Chi-Yang Tseng, Yu-Hsuan Fu, Da-Liang Ou

|Aug 09, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.

Wan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai

|Nov 02, 2022
Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer.

Kuo-Hsing Chen, Chia-Lang Hsu, Yu-Li Su

Pageof 3

Frequent Collaborators

5 joint publications

Da-Liang Ou

5 joint publications

Yu-Hsuan Fu

5 joint publications

Jeng-Wei Lu

4 joint publications

Hwei-Fang Tien